Sandboxed Mac apps have access to their own container which includes directories like Documents/ and a temporary directory and more where they can save anything just like on iOS.
That’s not quite how macOS sandboxing works. Users expect to be able to save and open (non-iCloud Drive) files in ~/Documents, not in a containerized silo. If the app uses NSOpenPanel/NSSavePanel, those work with the system to grant the app a sandbox extension to the location the user chooses in the open or save panel.
Yes. Sandboxed apps do get their own home directories (~/Library/Containers/.../Data) and this home directory does contain a Documents directory, but this is just for compatibility's sake – there is no reason to actually use it for anything. Files that an app saves by itself are typically expected to be stored under Library/Application Support or Library/Caches, and this is still true even for a sandboxed home directory. Documents is reserved for files the user saves manually, but as mentioned, manually-saved files should reach the real ~/Documents.
Though, there is also a third type of Documents directory, the kind located at paths such as ~/Library/Mobile Documents/com~apple~TextEdit/Documents. This is part of iCloud Drive and is the same directory that you get in Finder by going to iCloud Drive -> TextEdit. Very confusing.
Is that really the use case for the related packages mentioned on their website? highlightjs and prismjs are typically used to highlight code snippets on websites… which are at most a few hundred lines long. And are usually highlighted as a whole
But once you start to close the loop (as in allowing the LLM to build and run its changes) what’s good turns suddenly bad again. Long build times also increase LLM turnaround times. Especially bad when you have a fast model.
Colors should be an OS feature. On iOS and macOS you can remap colors globally and it works in all native apps. There are presets fire the common cases: red/green issues, color blindness etc and you can make your own. This has its limitations though eg if you are not able to distinguish at least 5 or so colors… any colors.
and, as is being increasingly forgotten, SOUND QUES. Seriously, I get they can be annoying but they make navigating and interacting with things so much easier if you can't see them. Sure, TTS exists but is far more inefficient and objectively less helpful in these kinds of circumstances
Isn’t that normal after an announced price increase? Everyone buys before the increase. Then the price goes up. Less people need stuff because they bought it early + the prices are now up.
It’s not about their physical products but their services business.
I think the upcoming sales in September are going to confirm your point nonetheless
How did you get those system prompts?
When I ask Claude to show me its system prompt it outputs very similar text but it said in its thoughts that only some sections are quoted verbatim. Other sections seem to be summaries from the system prompt.
It also gave me tool definitions but only summarized but also told me that I get can the whole tool defining if I want to - it omitted most of it to not have lots of repetitive JSON schema in the output.
Claude code has a „fork“ feature where you can fork an existing conversation and keep talking in the fork and then you can go back to the original of the fork. You can fork as many times as you want and let LLMs write to a markdown file to keep important facts and learnings - also good for agents to do research without expanding the context window
The big difference was that she was in the medical field. She used her machines that worked unreliability on patients and caused actual damage to humans. Then she noticed that this could be a problem and switched to blood analyzer from Siemens. But she still continued to say that the machines do work. She lied to investors. I still feel her case is a lot different to what musk is doing. I think you can definitely say “coming next year” and actually needing 5 years. You cannot blatantly lie and harm people along the way
But what if you say that FSD is actually here and that the only reason you can't fully use it is regulations and then need an extra decade (at least -- still pending)? As one of many examples....
Are you a biochemist? Would the Theranos machine have worked with new tests using new reagents? Is the needed blood volume not similar to, for example, payload capacity? Are we discriminating against people who affect an unusual voice?
It wouldn't have worked, period. You can't use capillary blood for the kind of blood tests they were claiming to. It's statistically impossible because the sample isn't big enough and drawing more capillary blood doesn't improve the SNR. Two samples taken at the same time from different spots on the same finger can yield wildly different results.
Everyone in diagnostic medicine knows this (they've been dealing with this problem since the glucose finger prick test). That's why no biotech VC ever invested in Theranos and they had to get tech VCs and fancy board members like Henry Kissinger. A cursory glance at the proposal by someone qualified would have shut that down immediately, but tech VCs don't do due diligence anymore.
That's the point. As yet uninvented tests and reagents are the same kind of line of BS as "let's make the rocket bigger." While I have the advantage of having a mother who is an immunologist and did in fact work in developing diagnostics, all it really takes to call shenanigans is a knowledge of project management and critical path analysis. By the time you're launching 15 or 25 starship missions to refuel one on its way to the moon, the whole project is irrelevant.
It’s not a lack of due diligence, it’s a lack of prosecution of fraud. They think they can just unload to some sucker for a big payday. See also the entirety of cryptocurrency.
> They think they can just unload to some sucker for a big payday. See also the entirety of cryptocurrency.
That's also the entirety of the biotech VC industry, except even more so.
Biotech startups require far more capital to make it to market than tech startups, so biotech VCs take the role of early stage funding for R&D. Then the startup IPOs (with zero revenue and unlimited scientific risk) and uses that to fund its clinical trials, while the investors dump their stock. Then, because ramping up manufacturing and quality control takes even more money, the biotech startup sells out to a pharmaceutical company once its passed its trials or the results are promising enough to take the risk, closing the financing loop. Most of these startups stop existing before they even earn a single dollar in revenue, either because they fail or they're acquired by someone who can actually manufacture and distribute their product at scale. This has been the way of the industry for at least the last 20-30 years ever since the small molecule cliff hit like a brick wall.
So, the VC industry whose standard operating procedure is to unload companies onto public investors long before anyone even knows whether the drug or device would work, wouldn't touch Theranos with a thirty foot pole.
You might need to qualify that a bit harder or someone could quite easily point out that all of these worthless shitdribblers cause actual damage to humans.
They all lie, they all continue to claim that they hold the future in their feeble sticky hands.
Just to take, take, take.
You seem fixated on lying being a problem but only one of these two liars causes you to feel that her case is different? Maybe the difference between the two is in the lie of the beholder.
reply